Consolidated Statement Of Changes In Redeemable Convertible Preferred Stock And Stockholders' (Deficit) Equity (USD $)
In Thousands, except Share data |
Total
USD ($)
|
Series A 12% convertible preferred stock
USD ($)
|
Series C super dividend convertible preferred stock
USD ($)
|
Series B-1 12% redeemable convertible preferred stock
USD ($)
|
Series B-2 12% redeemable convertible preferred stock
USD ($)
|
Series C super dividend convertible preferred stock
USD ($)
|
Series A 12% convertible preferred stock
USD ($)
|
Common Stock
USD ($)
|
Common Stock
Series A 12% convertible preferred stock
|
Common Stock
Series B-1 12% redeemable convertible preferred stock
|
Common Stock
Series B-2 12% redeemable convertible preferred stock
|
Common Stock
Series C super dividend convertible preferred stock
|
Additional Paid-In Capital
USD ($)
|
Additional Paid-In Capital
Series A 12% convertible preferred stock
USD ($)
|
Additional Paid-In Capital
Series B-1 12% redeemable convertible preferred stock
USD ($)
|
Additional Paid-In Capital
Series B-2 12% redeemable convertible preferred stock
USD ($)
|
Additional Paid-In Capital
Series C super dividend convertible preferred stock
USD ($)
|
Deficit Accumulated During the Development Stage
USD ($)
|
Deficit Accumulated During the Development Stage
Series A 12% convertible preferred stock
USD ($)
|
Deficit Accumulated During the Development Stage
Series B-1 12% redeemable convertible preferred stock
USD ($)
|
Deficit Accumulated During the Development Stage
Series B-2 12% redeemable convertible preferred stock
USD ($)
|
Deficit Accumulated During the Development Stage
Series C super dividend convertible preferred stock
USD ($)
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Beginning Balance at Dec. 31, 2012 | $ 1,165 | $ 1,698 | $ 2,900 | $ 2,154 | $ 632 | $ 16 | $ 80,535 | $ (80,018) | ||||||||||||||
Beginning Balance (in shares) at Dec. 31, 2012 | 900,000 | 2,100,000 | 220 | 1,562,500 | 16,060,853 | |||||||||||||||||
Accretion of Series B redeemable convertible preferred stock | (43) | 4 | 39 | (43) | ||||||||||||||||||
Accretion of beneficial conversion feature for Series B-2 | (13) | 13 | (13) | |||||||||||||||||||
Convertible preferred stock dividend (in shares) | 15,625 | 14,580 | 34,020 | 17,114 | ||||||||||||||||||
Convertible preferred stock dividend | 47 | 33 | 57 | 52 | 122 | 62 | (10) | (52) | (122) | (29) | ||||||||||||
Conversion of Series C to common stock (in shares) | (5) | 8,475 | ||||||||||||||||||||
Conversion of Series C to common stock | 49 | (49) | 49 | |||||||||||||||||||
Issuance of common stock upon exercise of options (in shares) | 39,762 | 39,762 | ||||||||||||||||||||
Issuance of common stock upon exercise of options | 77 | 77 | ||||||||||||||||||||
Stock-based compensation expense | 852 | 852 | ||||||||||||||||||||
Net loss | (3,203) | (3,203) | ||||||||||||||||||||
Ending Balance at Mar. 31, 2013 | $ (1,036) | $ 1,702 | $ 2,952 | $ 2,105 | $ 632 | $ 16 | $ 81,806 | $ (83,490) | ||||||||||||||
Ending Balance (in shares) at Mar. 31, 2013 | 900,000 | 2,100,000 | 215 | 1,562,500 | 16,190,429 |